← Leaderboards
Kenneth P. Mackie
Queen'S Medical Center
$20,190,412
Attributed
$29,897,515
Total exposure
26
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,293,741 · 27
By mechanism
R01$16,389,665 · 8
P30$5,767,125 · 2
U01$3,830,637 · 1
R21$2,937,140 · 7
P01$1,983,862 · 3
K05$1,344,615 · 1
Top collaborators
- Andrea Grace Hohmann16 shared
- Olivier Jj Manzoni10 shared
- Hui-Chen Lu8 shared
- Reinhold Penner5 shared
- Feng Guo3 shared
- Anna Kalinovsky2 shared
- Alexander J Straiker2 shared
- Patrick Donovan Quinn1 shared
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingCannabinoidsEndocannabinoidsSignal TransductionCannabisChronicNeuronsBaseCellsAgonistMolecularCannabinoid ReceptorAffectBehaviorReceptorExperimental StudyLeadReceptor SignalingPlayCnr1 GeneBrainPreventSignal PathwayPharmaceutical Preparations
Grant awards (107)
Indiana University Bloomington (IUB) Center for Cannabis, Cannabinoids, and Addiction (C3A)$1,359,039
P30 · FY2025 · DA · contact PI
Modulation of pain mechanisms by cannabis-derived phytochemicals.$574,379
R01 · FY2025 · AT
IUB C3A Administrative Core$455,822
P30 · FY2025 · DA · contact PI
Mechanisms and treatment of adolescent phytocannabinoid impairment of prefrontal cortex function$427,962
R01 · FY2025 · DA
INTEGRATIVE PREDOCTORAL TRAINING IN DRUG ABUSE RESEARCH AT INDIANA UNIVERSITY$216,204
T32 · FY2025 · DA · contact PI
Negative allosteric modulation of mu opioid receptors to reverse fentanyl overdose$198,125
R21 · FY2025 · DA · contact PI
Indiana University Bloomington (IUB) Center for Cannabis, Cannabinoids, and Addiction (C3A)$1,362,472
P30 · FY2024 · DA · contact PI
An automated portable system for detecting and treating opioid induced respiratory depression$1,203,029
U01 · FY2024 · DA · contact PI
Modulation of pain mechanisms by cannabis-derived phytochemicals.$630,805
R01 · FY2024 · AT
IUB C3A Administrative Core$459,255
P30 · FY2024 · DA · contact PI
Mechanisms and treatment of adolescent phytocannabinoid impairment of prefrontal cortex function$427,962
R01 · FY2024 · DA
Negative allosteric modulation of mu opioid receptors to reverse fentanyl overdose$237,750
R21 · FY2024 · DA · contact PI
INTEGRATIVE PREDOCTORAL TRAINING IN DRUG ABUSE RESEARCH AT INDIANA UNIVERSITY$163,780
T32 · FY2024 · DA · contact PI
Indiana University Bloomington (IUB) Center for Cannabis, Cannabinoids, and Addiction (C3A)$1,674,715
P30 · FY2023 · DA · contact PI
An automated portable system for detecting and treating opioid induced respiratory depression$1,278,121
U01 · FY2023 · DA · contact PI
Modulation of pain mechanisms by cannabis-derived phytochemicals.$638,190
R01 · FY2023 · AT
CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence$517,184
R01 · FY2023 · DA
IUB C3A Administrative Core$455,822
P30 · FY2023 · DA · contact PI
Mechanisms and treatment of adolescent phytocannabinoid impairment of prefrontal cortex function$440,092
R01 · FY2023 · DA
INTEGRATIVE PREDOCTORAL TRAINING IN DRUG ABUSE RESEARCH AT INDIANA UNIVERSITY$231,250
T32 · FY2023 · DA · contact PI
An automated portable system for detecting and treating opioid induced respiratory depression$1,349,487
U01 · FY2022 · DA · contact PI
Modulation of pain mechanisms by cannabis-derived phytochemicals.$643,672
R01 · FY2022 · AT
CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence$517,184
R01 · FY2022 · DA
Mechanisms and treatment of adolescent phytocannabinoid impairment of prefrontal cortex function$488,971
R01 · FY2022 · DA
Perinatal cannabinoids delay KCC2 expression and lead to neurodevelopmental abnormalities$309,377
R01 · FY2022 · DA · contact PI
INTEGRATIVE PREDOCTORAL TRAINING IN DRUG ABUSE RESEARCH AT INDIANA UNIVERSITY$227,181
T32 · FY2022 · DA · contact PI
Modulation of pain mechanisms by cannabis-derived phytochemicals.$663,415
R01 · FY2021 · AT
CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence$517,184
R01 · FY2021 · DA
Sex-specific critical periods determine the effects of cannabinoids on the mesocorticolimbic system$310,657
R01 · FY2021 · DA · contact PI
Perinatal cannabinoids delay KCC2 expression and lead to neurodevelopmental abnormalities$309,837
R01 · FY2021 · DA · contact PI
INTEGRATIVE PREDOCTORAL TRAINING IN DRUG ABUSE RESEARCH AT INDIANA UNIVERSITY$214,088
T32 · FY2021 · DA · contact PI
CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence$517,184
R01 · FY2020 · DA
Role of CB2 in Analgesic Mechanisms$351,000
R01 · FY2020 · DA
Sex-specific critical periods determine the effects of cannabinoids on the mesocorticolimbic system$309,985
R01 · FY2020 · DA · contact PI
Perinatal cannabinoids delay KCC2 expression and lead to neurodevelopmental abnormalities$309,754
R01 · FY2020 · DA · contact PI
INTEGRATIVE PREDOCTORAL TRAINING IN DRUG ABUSE RESEARCH AT INDIANA UNIVERSITY$211,858
T32 · FY2020 · DA · contact PI
CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence$517,184
R01 · FY2019 · DA
Role of CB2 in Analgesic Mechanisms$351,000
R01 · FY2019 · DA
Perinatal cannabinoids delay KCC2 expression and lead to neurodevelopmental abnormalities$310,099
R01 · FY2019 · DA · contact PI
Sex-specific critical periods determine the effects of cannabinoids on the mesocorticolimbic system$297,979
R01 · FY2019 · DA · contact PI
Cannabinoids play a central role in cerebellar development$196,875
R21 · FY2019 · DA
Role of CB2 in Analgesic Mechanisms$351,000
R01 · FY2018 · DA
Perinatal cannabinoids delay KCC2 expression and lead to neurodevelopmental abnormalities$323,667
R01 · FY2018 · DA · contact PI
Sex-specific critical periods determine the effects of cannabinoids on the mesocorticolimbic system$298,313
R01 · FY2018 · DA · contact PI
Cannabinoids play a central role in cerebellar development$236,250
R21 · FY2018 · DA
Exploiting CB2 Functional Selectivity for Therapeutic Benefit$234,500
P01 · FY2018 · DA · contact PI
Does GPR119 mediate the beneficial metabolic effects of THC?$196,875
R21 · FY2018 · DA · contact PI
Role of CB2 in Analgesic Mechanisms$351,000
R01 · FY2017 · DA
Sex-specific critical periods determine the effects of cannabinoids on the mesocorticolimbic system$311,445
R01 · FY2017 · DA · contact PI
Exploiting CB2 Functional Selectivity for Therapeutic Benefit$234,500
P01 · FY2017 · DA · contact PI
Does GPR119 mediate the beneficial metabolic effects of THC?$196,406
R21 · FY2017 · DA · contact PI
Cannabinoid Modulation of Cell Function$139,326
K05 · FY2017 · DA · contact PI
Role of CB2 in Analgesic Mechanisms$351,000
R01 · FY2016 · DA
Exploiting CB2 Functional Selectivity for Therapeutic Benefit$232,154
P01 · FY2016 · DA · contact PI
Adolescent THC, microglial activation, neuroinflammation, and their long-term consequences$231,660
R21 · FY2016 · DA · contact PI
Cannabinoid Modulation of Cell Function$139,326
K05 · FY2016 · DA · contact PI
Exploiting CB2 Functional Selectivity for Therapeutic Benefit$230,406
P01 · FY2015 · DA · contact PI
Adolescent THC, microglial activation, neuroinflammation, and their long-term consequences$195,000
R21 · FY2015 · DA · contact PI
Cannabinoid Modulation of Cell Function$139,326
K05 · FY2015 · DA · contact PI
Neuronal cannabinoids$298,760
R01 · FY2014 · DA · contact PI
Optimizing analgesia by exploiting CB2 agonist functional selectivity$234,000
R21 · FY2014 · DA · contact PI
Exploiting CB2 Functional Selectivity for Therapeutic Benefit$230,502
P01 · FY2014 · DA · contact PI
Cannabinoid Modulation of Cell Function$139,326
K05 · FY2014 · DA · contact PI
Neuronal cannabinoids$286,810
R01 · FY2013 · DA · contact PI
Optimizing analgesia by exploiting CB2 agonist functional selectivity$195,000
R21 · FY2013 · DA · contact PI
Cannabinoid Modulation of Cell Function$139,326
K05 · FY2013 · DA · contact PI
Neuronal cannabinoids$298,760
R01 · FY2012 · DA · contact PI
Neuronal cannabinoids$298,760
R01 · FY2011 · DA · contact PI
Will therapeutic dosing of fatty acid amino hydrolase inhibitors disrupt neuronal$221,400
R21 · FY2011 · HD · contact PI
Do organophosphates impair neurodevelopment through inhibition of endocannabinoid$186,423
R21 · FY2011 · DA · contact PI
Molecular Requirements of Cannabinoid Receptor Activity$170,640
P01 · FY2011 · DA · contact PI
Cannabinoid Modulation of Cell Function$129,597
K05 · FY2011 · DA · contact PI
Cannabinoid$15,000
R13 · FY2011 · DA · contact PI
Neuronal cannabinoids$308,000
R01 · FY2010 · DA · contact PI
Will therapeutic dosing of fatty acid amino hydrolase inhibitors disrupt neuronal$205,688
R21 · FY2010 · HD · contact PI
Do organophosphates impair neurodevelopment through inhibition of endocannabinoid$205,688
R21 · FY2010 · DA · contact PI
Molecular Requirements of Cannabinoid Receptor Activity$170,937
P01 · FY2010 · DA · contact PI
Cannabinoid Modulation of Cell Function$129,597
K05 · FY2010 · DA · contact PI
Cannabinoid$1
R13 · FY2010 · DA · contact PI
Role of endogenous vanilloids and cannabinoids in pain$329,273
R01 · FY2009 · DA · contact PI
Molecular Requirements of Cannabinoid Receptor Activity$178,014
P01 · FY2009 · DA · contact PI
Cannabinoid Modulation of Cell Function$129,597
K05 · FY2009 · DA · contact PI
Cannabinoid$15,000
R13 · FY2009 · DA · contact PI
Role of endogenous vanilloids and cannabinoids in pain$329,286
R01 · FY2008 · DA · contact PI
NEURONAL CANNABINOID RECEPTOR: FUNCTION AND REGULATION$246,359
R01 · FY2008 · DA · contact PI
Molecular Requirements of Cannabinoid Receptor Activity$183,979
P01 · FY2008 · DA · contact PI
Cannabinoid Modulation of Cell Function$129,597
K05 · FY2008 · DA · contact PI
Cannabinoid$1
R13 · FY2008 · DA · contact PI
NEURONAL CANNABINOID RECEPTOR: FUNCTION AND REGULATION$251,553
R01 · FY2007 · DA · contact PI
Cannabinoid Modulation of Cell Function$129,597
K05 · FY2007 · DA · contact PI
Molecular Requirements of Cannabinoid Receptor Activity$118,230
P01 · FY2007 · DA · contact PI
Cannabinoid$15,000
R13 · FY2007 · DA · contact PI
2007 CB2 Cannabinoid Meeting$8,800
R13 · FY2007 · DA · contact PI
NEURONAL CANNABINOID RECEPTOR: FUNCTION AND REGULATION$259,066
R01 · FY2006 · DA · contact PI
NEURONAL CANNABINOID RECEPTOR: FUNCTION AND REGULATION$265,300
R01 · FY2005 · DA
Cannabinoid Modulation of Neuronal Function$118,390
K02 · FY2005 · DA
2005 Cannabinoid Function in the CNS Gordon Conference$12,000
R13 · FY2005 · DA
NEURONAL CANNABINOID RECEPTOR: FUNCTION AND REGULATION$282,560
R01 · FY2004 · DA
Cannabinoid Modulation of Neuronal Function$118,390
K02 · FY2004 · DA
Cannabinoid Modulation of Neuronal Function$118,390
K02 · FY2003 · DA
NEURONAL CANNABINOID RECEPTOR--FUNCTION AND REGULATION$182,253
R01 · FY2002 · DA
Cannabinoid Modulation of Neuronal Function$118,390
K02 · FY2002 · DA
CANNABINOID DESENSITIZATION MECHANISMS$0
P01 · FY2002 · DA
NEURONAL CANNABINOID RECEPTOR--FUNCTION AND REGULATION$176,647
R01 · FY2001 · DA
Cannabinoid Modulation of Neuronal Function$118,390
K02 · FY2001 · DA
NEURONAL CANNABINOID RECEPTOR--FUNCTION AND REGULATION$208,797
R01 · FY2000 · DA
CANNABINOID MODULATION OF NEURONAL FUNCTION$118,584
K02 · FY2000 · DA